GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MeiraGTx Holdings PLC (NAS:MGTX) » Definitions » Beneish M-Score

MeiraGTx Holdings (MeiraGTx Holdings) Beneish M-Score : -3.27 (As of Apr. 30, 2024)


View and export this data going back to 2018. Start your Free Trial

What is MeiraGTx Holdings Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.27 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for MeiraGTx Holdings's Beneish M-Score or its related term are showing as below:

MGTX' s Beneish M-Score Range Over the Past 10 Years
Min: -3.39   Med: -2.64   Max: -1.73
Current: -3.27

During the past 8 years, the highest Beneish M-Score of MeiraGTx Holdings was -1.73. The lowest was -3.39. And the median was -2.64.


MeiraGTx Holdings Beneish M-Score Historical Data

The historical data trend for MeiraGTx Holdings's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MeiraGTx Holdings Beneish M-Score Chart

MeiraGTx Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial - -1.73 -2.01 -3.39 -3.27

MeiraGTx Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.39 0.73 5.62 0.88 -3.27

Competitive Comparison of MeiraGTx Holdings's Beneish M-Score

For the Biotechnology subindustry, MeiraGTx Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MeiraGTx Holdings's Beneish M-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MeiraGTx Holdings's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where MeiraGTx Holdings's Beneish M-Score falls into.



MeiraGTx Holdings Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of MeiraGTx Holdings for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9163+0.528 * 1+0.404 * 1.0811+0.892 * 0.8805+0.115 * 0.6549
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.1539+4.679 * -0.130588-0.327 * 0.8695
=-3.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $23.42 Mil.
Revenue was 2.04 + 5.103 + 3.54 + 3.334 = $14.02 Mil.
Gross Profit was 2.04 + 5.103 + 3.54 + 3.334 = $14.02 Mil.
Total Current Assets was $159.62 Mil.
Total Assets was $326.74 Mil.
Property, Plant and Equipment(Net PPE) was $156.24 Mil.
Depreciation, Depletion and Amortization(DDA) was $13.72 Mil.
Selling, General, & Admin. Expense(SGA) was $47.29 Mil.
Total Current Liabilities was $67.08 Mil.
Long-Term Debt & Capital Lease Obligation was $85.07 Mil.
Net Income was 20.215 + -44.297 + -29.581 + -30.364 = $-84.03 Mil.
Non Operating Income was 66.869 + -8.677 + 1.904 + 3.911 = $64.01 Mil.
Cash Flow from Operations was -14.547 + -24.414 + -29.012 + -37.392 = $-105.37 Mil.
Total Receivables was $29.02 Mil.
Revenue was -5.288 + 4.816 + 10.759 + 5.633 = $15.92 Mil.
Gross Profit was -5.288 + 4.816 + 10.759 + 5.633 = $15.92 Mil.
Total Current Assets was $154.34 Mil.
Total Assets was $318.24 Mil.
Property, Plant and Equipment(Net PPE) was $154.09 Mil.
Depreciation, Depletion and Amortization(DDA) was $8.60 Mil.
Selling, General, & Admin. Expense(SGA) was $46.55 Mil.
Total Current Liabilities was $82.07 Mil.
Long-Term Debt & Capital Lease Obligation was $88.36 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(23.415 / 14.017) / (29.023 / 15.92)
=1.670472 / 1.823053
=0.9163

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(15.92 / 15.92) / (14.017 / 14.017)
=1 / 1
=1

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (159.622 + 156.238) / 326.744) / (1 - (154.339 + 154.093) / 318.237)
=0.03331 / 0.03081
=1.0811

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=14.017 / 15.92
=0.8805

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(8.603 / (8.603 + 154.093)) / (13.724 / (13.724 + 156.238))
=0.052878 / 0.080747
=0.6549

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(47.293 / 14.017) / (46.55 / 15.92)
=3.373974 / 2.923995
=1.1539

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((85.071 + 67.078) / 326.744) / ((88.364 + 82.072) / 318.237)
=0.465652 / 0.535563
=0.8695

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-84.027 - 64.007 - -105.365) / 326.744
=-0.130588

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

MeiraGTx Holdings has a M-score of -3.27 suggests that the company is unlikely to be a manipulator.


MeiraGTx Holdings Beneish M-Score Related Terms

Thank you for viewing the detailed overview of MeiraGTx Holdings's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


MeiraGTx Holdings (MeiraGTx Holdings) Business Description

Traded in Other Exchanges
Address
450 East 29th Street, 14th Floor, New York, NY, USA, 10016
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
Executives
Perceptive Life Sciences Master Fund Ltd director, 10 percent owner C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Johnson & Johnson Innovation - Jjdc, Inc. 10 percent owner 410 GEORGE STREET, NEW BRUNSWICK NJ 08901
Johnson & Johnson 10 percent owner ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK NJ 08933
Robert K Zeldin officer: Chief Medical Officer C/O ACCELERON PHARMA INC., 128 SIDNEY STREET, CAMBRIDGE MA 02139
Robert J Wollin officer: General Counsel and Secretary 450 EAST 29TH STREET, 14TH FLOOR, NEW YORK NY 10016
Debra Yu director C/O PERCEPTIVE ADVISORS, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Alexandria Forbes director, officer: President & CEO C/O KADMON HOLDINGS, LLC, 450 E. 29TH STREET, NEW YORK NY 10016
Richard Giroux officer: Chief Operating Officer C/O MEIRAGTX - US, 430 EAST 29TH STREET, 10TH FLOOR, NEW YORK NY 10016
Stuart Naylor director, officer: Chief Dev. Officer C/O MEIRAGTX - US, 430 EAST 29TH STREET, 10TH FLOOR, NEW YORK NY 10016
Joel S Marcus director C/O ALEXANDRIA REAL ESTATE EQUITIES, INC, 26 NORTH EUCLID AVENUE, PASADENA CA 91101
Thomas E Shenk director C/O KADMON HOLDINGS, LLC, 450 E. 29TH STREET, NEW YORK NY 10016
Nicole Seligman director C/O VIACOM INC., 1515 BROADWAY, NEW YORK NY 10036
Perceptive Advisors Llc director, 10 percent owner 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Joseph Edelman 10 percent owner C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Ellen Hukkelhoven director C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003

MeiraGTx Holdings (MeiraGTx Holdings) Headlines

From GuruFocus

MeiraGTx Announces $60 Million Private Placement of Ordinary Shares

By sperokesalga sperokesalga 05-03-2023

MeiraGTx to Participate in Upcoming Investor Conferences

By sperokesalga sperokesalga 04-20-2023

MeiraGTx to Participate in Upcoming Investor Conferences

By Value_Insider Value_Insider 11-22-2022